UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

 

Filed by the Registrant ☒

 

Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

☐ Preliminary Proxy Statement
   
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   
☐ Definitive Proxy Statement
   
☒ Definitive Additional Materials
   
☐ Soliciting Material Pursuant to § 240.14a-12

 

CONDUIT PHARMACEUTICALS INC.

(Name of Registrant as Specified in its Charter)

 

 

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

☒ No fee required.
   
☐ Fee paid previously with preliminary materials
   
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

 

 

 

Conduit Pharmaceuticals (NASDAQ:CDTTW)
Historical Stock Chart
Von Mär 2025 bis Apr 2025 Click Here for more Conduit Pharmaceuticals Charts.
Conduit Pharmaceuticals (NASDAQ:CDTTW)
Historical Stock Chart
Von Apr 2024 bis Apr 2025 Click Here for more Conduit Pharmaceuticals Charts.